Feb 24, 2023
January 25, 2025
This week’s newsletter included:
-
Still on the Hill…
-
Meet Mark Paul –– New Executive Director of the Center for Medical Innovation
-
PIVOT Center Welcomes New Executive Director of Technology Commercialization
-
SDNA Saliva Collection FDA 510(k) Class II Medical Device Clearance
-
This Quiet Utah Company Has Become a Global Life Sciences Software Leader Worth $1.3 Billion
-
Thermo Fisher Scientific Increases Quarterly Dividend
-
Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2022 and Issues Fiscal Year 2023 Guidance
-
Merit Medical Receives FDA Breakthrough Device Designation for the New SCOUT® MD™ Surgical Guidance System
-
Clene: Still in the Running for ALS
-
The Power of MedTech: Utah
-
100 Companies Championing Women Nomination Application
Recent News
- bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
- DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
- 2025 BIO International Recap
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
- Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services
- RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS
